These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27776587)

  • 1. Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
    Garcia-Prats AJ; du Plessis L; Draper HR; Burger A; Seddon JA; Zimri K; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2016 Nov; 20(11):1469-1476. PubMed ID: 27776587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    Rockwood N; Sirgel F; Streicher E; Warren R; Meintjes G; Wilkinson RJ
    J Infect Dis; 2017 Sep; 216(6):632-640. PubMed ID: 28934422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mycobacterial drug resistance patterns on patients' survival: a cohort study in Thailand.
    Anuwatnonthakate A; Whitehead SJ; Varma JK; Silachamroon U; Kasetjaroen Y; Moolphate S; Limsomboon P; Inyaphong J; Suriyon N; Kavinum S; Chiengson N; Tunteerapat P; Kaewkungwal J
    Glob J Health Sci; 2013 Aug; 5(6):60-72. PubMed ID: 24171875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
    Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis.
    Zhang L; Han X; Ge Q; Shu W; Sun Y; Gao J; Xie S; Wang J; Gao W
    BMC Infect Dis; 2024 Jan; 24(1):7. PubMed ID: 38166793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.
    Saldanha N; Runwal K; Ghanekar C; Gaikwad S; Sane S; Pujari S
    BMC Infect Dis; 2019 May; 19(1):391. PubMed ID: 31068153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
    Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
    BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The therapeutic effect of regimens containing isoniazid and rifampicin for pulmonary tuberculosis with single isoniazid or rifampicin resistance].
    Tan S; Ding X; Tan Y; Cai X; Li Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Dec; 37(12):915-8. PubMed ID: 25609129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.
    van der Laan LE; Garcia-Prats AJ; Schaaf HS; Tikiso T; Wiesner L; de Kock M; Winckler J; Norman J; McIlleron H; Denti P; Hesseling AC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
    Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance provides insight into epidemiology and spectrum of culture-confirmed mycobacterial disease in children.
    Schaaf HS; Garcia-Prats AJ; du Preez K; Rautenbach C; Hesseling AC
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1249-56. PubMed ID: 27510254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes and factors associated with unfavourable outcome among previously treated tuberculosis patients with isoniazid resistance in four regions of Cameroon.
    Kuaban C; Toukam LDI; Sander M
    Pan Afr Med J; 2020; 37():45. PubMed ID: 33209172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and outcome in children admitted to a TB hospital in the Western Cape--the influence of HIV infection and drug resistance.
    Soeters M; de Vries AM; Kimpen JL; Donald PR; Schaaf HS
    S Afr Med J; 2005 Aug; 95(8):602-6. PubMed ID: 16201005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
    Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
    BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in Drug Resistance in Childhood Tuberculosis in Cape Town, South Africa.
    Schaaf HS; Garcia-Prats AJ; Draper HR; Rautenbach C; Bosch C; Demers AM; Hesseling AC; Walters E
    Pediatr Infect Dis J; 2020 Jul; 39(7):604-608. PubMed ID: 32520889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.